A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
“The Publication Plan” has launched its official Facebook page, as a new platform to share news and information with authors, researchers, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and … Continue Reading “The Publication Plan” is now also launched on Facebook
Christian Gumpenberger, Wolfgang Glanzel and Juan Gorraiz have recently published an article looking at the rapid rise of the altmetric phenomenon, and highlighting their concerns regarding the general acceptance of … Continue Reading Concerns raised about the interpretation of altmetric scores
Last week, Altmetric and MedComms Networking hosted a day-long seminar in London to discuss the use of alternative metrics for tracking engagement with industry-sponsored publications. The day kicked off with … Continue Reading Summary of Altmetric seminar: “Research with results: Tracking engagement for medcomms and pharma”
According to a major study of how research is shared, articles that feature in open access journals are more likely to be cited on Twitter. Kim Holmberg, a research associate … Continue Reading Open access papers ‘more likely to be cited on Twitter’ (@kholmber)
An article published by Nature in the past week summarises a new initiative that uses colourful ‘digital badges’ to denote different contributions that authors made to a paper. This system … Continue Reading Digital badges aim to clear up politics of authorship
A Wiley blog this week discusses the potential pitfalls associated with Altmetrics, including “the misappropriation of the term impact, the narrow scope of focus, and the potential goal displacement of … Continue Reading Challenges associated with #altmetrics: “attention is not impact”
This poster was presented at the recent DIA 2015 meeting in Washington DC. To access the PDF of the article, then please click here.